Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions

por Ray, Emily M, Sanoff, Hanna K
Publicado 2017

Qualitative evaluation of barriers and facilitators to hepatocellular carcinoma care in North Carolina

por Ray, Emily M., Teal, Randall W., Carda-Auten, Jessica, Coffman, Erin, Sanoff, Hanna K.
Publicado 2023

Pleomorphic Invasive Lobular Carcinoma of the Breast With Extracellular Mucin and HER2 Amplification

por Burky, Matthew J, Ray, Emily M, Ollila, David W, O’Connor, Siobhan M., Hertel, Johann D., Calhoun, Benjamin C
Publicado 2020

Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic

por Osterman, Chelsea K., Triglianos, Tammy, Winzelberg, Gary S., Nichols, Angela D., Rodriguez-O’Donnell, Julia, Bigelow, Sharon M., van Deventer, Hendrik, Sanoff, Hanna K., Ray, Emily M.
Publicado 2020

A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and...

por Nakamura, Zev M., Deal, Allison M., Park, Eliza M., Stanton, Kate E., Lopez, Yesy E., Quillen, Laura J., O’Hare Kelly, Erin, Heiling, Hillary M., Nyrop, Kirsten A., Ray, Emily M., Dees, E. Claire, Reeder‐Hayes, Katherine E., Jolly, Trevor A., Carey, Lisa A., Abdou, Yara, Olajide, Oludamilola A., Rauch, Julia K., Joseph, Ranjit, Copeland, Anureet, McNamara, Megan A., Ahles, Tim A., Muss, Hyman B.
Publicado 2023